Latest news for  (OTC:ICSTF) Stock

SXTP

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

SXTPW

JP Morgan analyst David Karnovsky maintains TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) with a Overweight and raises the price target from $126 to $132.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on TKO Group Holdings, Raises Price Target to $132

JP Morgan analyst Peter Peng maintains Synaptics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) with a Overweight and lowers the price target from $120 to $100.

SYNA

JP Morgan Maintains Overweight on Synaptics, Lowers Price Target to $100

JP Morgan analyst Andrea Teixeira maintains SharkNinja (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) with a Overweight and raises the price target from $80 to $97.

JP Morgan Maintains Overweight on SharkNinja, Raises Price Target to $97

JP Morgan analyst Paul Coster maintains Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Overweight and lowers the price target from $27 to $22.

ARRY

JP Morgan Maintains Overweight on Array Technologies, Lowers Price Target to $22

JP Morgan analyst Philip Cusick maintains Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) with a Neutral and lowers the price target from $10 to $8.

JP Morgan Maintains Neutral on Warner Bros. Discovery, Lowers Price Target to $8

JP Morgan analyst Andrea Teixeira maintains e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) with a Overweight and lowers the price target from $224 to $207.

JP Morgan Maintains Overweight on e.l.f. Beauty, Lowers Price Target to $207

JP Morgan analyst Ryan Lambert downgrades Hilton Grand Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGV#NYSE">HGV</a>) from Overweight to Neutral and lowers the price target from $55 to $36.

Downgrades

JP Morgan Downgrades Hilton Grand Vacations to Neutral, Lowers Price Target to $36

Citigroup analyst Paul Diamond maintains Permian Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) with a Buy and lowers the price target from $20 to $18.

Citigroup Maintains Buy on Permian Resources, Lowers Price Target to $18

Citigroup analyst Drew Foster maintains HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Buy and lowers the price target from $699 to $629.

HUBS

Citigroup Maintains Buy on HubSpot, Lowers Price Target to $629

Citigroup analyst Fatima Boolani maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and raises the price target from $305 to $310.

CYBR

Citigroup Maintains Buy on CyberArk Software, Raises Price Target to $310

Citigroup analyst Ygal Arounian maintains Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) with a Neutral and lowers the price target from $52 to $47.

Citigroup Maintains Neutral on Ziff Davis, Lowers Price Target to $47

Citigroup analyst Jon Tower maintains Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) with a Neutral and raises the price target from $30 to $32.

Citigroup Maintains Neutral on Sweetgreen, Raises Price Target to $32

Citigroup analyst Ygal Arounian maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Buy and raises the price target from $112 to $115.

Citigroup Maintains Buy on Trade Desk, Raises Price Target to $115

Citigroup analyst Samantha Semenkow maintains Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) with a Buy and raises the price target from $7 to $8.

ALLO

Citigroup Maintains Buy on Allogene Therapeutics, Raises Price Target to $8

Citigroup analyst Ronald Josey maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Neutral and raises the price target from $140 to $145.

EXPE

Citigroup Maintains Neutral on Expedia Group, Raises Price Target to $145

Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDRX#NASDAQ">GDRX</a>) with a Buy and lowers the price target from $11 to $10.

GDRX

Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $10

Citigroup analyst James Hardiman maintains Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Buy and lowers the price target from $64 to $61.

Citigroup Maintains Buy on Six Flags Entertainment, Lowers Price Target to $61

Citigroup analyst Samantha Semenkow maintains Catalyst Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>) with a Buy and raises the price target from $27 to $31.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

News

Latest news for (OTC:ICSTF) Stock